155 related articles for article (PubMed ID: 36092708)
1. NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression.
Tsujimoto G; Ito R; Yoshikawa K; Ueki C; Okada N
Front Cell Dev Biol; 2022; 10():983599. PubMed ID: 36092708
[TBL] [Abstract][Full Text] [Related]
2. NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma.
Li Z; You C; Huang J; Zhang M
Med Sci Monit; 2023 Jan; 29():e938410. PubMed ID: 36680333
[TBL] [Abstract][Full Text] [Related]
3. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.
Xiang J; Chen C; Liu R; Gou D; Chang L; Deng H; Gao Q; Zhang W; Tuo L; Pan X; Liang L; Xia J; Huang L; Yao K; Wang B; Hu Z; Huang A; Wang K; Tang N
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690219
[TBL] [Abstract][Full Text] [Related]
4. NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism.
Okada N; Ueki C; Shimazaki M; Tsujimoto G; Kohno S; Muranaka H; Yoshikawa K; Takahashi C
Commun Biol; 2023 Jun; 6(1):596. PubMed ID: 37268670
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
Liu MX; Jin L; Sun SJ; Liu P; Feng X; Cheng ZL; Liu WR; Guan KL; Shi YH; Yuan HX; Xiong Y
Oncogene; 2018 Mar; 37(12):1637-1653. PubMed ID: 29335519
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
[TBL] [Abstract][Full Text] [Related]
7. PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway.
Tuo L; Xiang J; Pan X; Gao Q; Zhang G; Yang Y; Liang L; Xia J; Wang K; Tang N
Front Oncol; 2018; 8():611. PubMed ID: 30619751
[TBL] [Abstract][Full Text] [Related]
8. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
[TBL] [Abstract][Full Text] [Related]
9. MiR-93-5P Represses the Gluconeogenesis of Hepatocellular Carcinoma while Boosting Its Glycolysis and Malignant Progression by Suppressing PCK1.
Zhou X; Huang L; Xing R; Yang F; Nie H
Crit Rev Eukaryot Gene Expr; 2022; 32(1):35-47. PubMed ID: 35377979
[TBL] [Abstract][Full Text] [Related]
10. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
[TBL] [Abstract][Full Text] [Related]
11. Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression.
Gou D; Liu R; Shan X; Deng H; Chen C; Xiang J; Liu Y; Gao Q; Li Z; Huang A; Wang K; Tang N
J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37166978
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of the Sonic Hedgehog (SHH) Gene Inhibits Proliferation of Hep3B and SMMC-7721 Hepatocellular Carcinoma Cells via the PI3K/Akt/PCK1 Signaling Pathway.
Chen Y; Zhu W
Med Sci Monit; 2019 Aug; 25():6023-6033. PubMed ID: 31406102
[TBL] [Abstract][Full Text] [Related]
13. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.
Xu D; Wang Z; Xia Y; Shao F; Xia W; Wei Y; Li X; Qian X; Lee JH; Du L; Zheng Y; Lv G; Leu JS; Wang H; Xing D; Liang T; Hung MC; Lu Z
Nature; 2020 Apr; 580(7804):530-535. PubMed ID: 32322062
[TBL] [Abstract][Full Text] [Related]
14. m 6 A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury.
Yu S; Liu X; Xu Y; Pan L; Zhang Y; Li Y; Dong S; Tu D; Sun Y; Zhang Y; Zhou Z; Liang X; Huang Y; Chu J; Tu S; Liu C; Chen H; Chen W; Ge M; Zhang Q
Hepatology; 2023 Dec; ():. PubMed ID: 38085830
[TBL] [Abstract][Full Text] [Related]
15. Glycine
Hughey CC; Trefts E; Bracy DP; James FD; Donahue EP; Wasserman DH
J Biol Chem; 2018 Jul; 293(30):11944-11954. PubMed ID: 29891549
[TBL] [Abstract][Full Text] [Related]
16. mTORC2 controls cancer cell survival by modulating gluconeogenesis.
Khan MW; Biswas D; Ghosh M; Mandloi S; Chakrabarti S; Chakrabarti P
Cell Death Discov; 2015; 1():15016. PubMed ID: 27551450
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2.
Malakar P; Stein I; Saragovi A; Winkler R; Stern-Ginossar N; Berger M; Pikarsky E; Karni R
Cancer Res; 2019 May; 79(10):2480-2493. PubMed ID: 30914432
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detected by RNA-seq.
Xiang J; Zhang Y; Tuo L; Liu R; Gou D; Liang L; Chen C; Xia J; Tang N; Wang K
Genes Dis; 2020 Mar; 7(1):150-159. PubMed ID: 32181286
[TBL] [Abstract][Full Text] [Related]
19. PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities.
Xiang J; Wang K; Tang N
Genes Dis; 2023 Jan; 10(1):101-112. PubMed ID: 37013052
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
